TABLE 6.
Groups | Total Prevalence, n = 401, % | PICU Mortality, n = 44, n (%) | Relative Risk (95% CI) |
---|---|---|---|
Single organ failure | 27.9 | 1/112 (0.9) | 0.09 (0.01–0.65) |
MOF | 72.1 | 43/289 (14.9) | Not applicable |
MOF no phenotype | 46.9 | 19/188 (10.1) | Reference |
MOF with phenotype | 25.2 | 24/101 (23.8) | 2.35 (1.36–4.08) |
Immunoparalysis associated MOF | 21.2 | 17/85 (20.0) | 1.98 (1.08–3.61) |
Thrombocytopenia associated MOF | 9.2 | 16/37 (43.2) | 4.28 (2.43–7.52) |
Sequential liver failure associated MOF | 1.7 | 3/7 (42.9) | 4.24 (1.63–11.03) |
MOF = multiple organ failure.
Results are based on individual univariable modified Poisson regression models.